The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
It should be clear that my risk/benefit profile does not apply to most people in need of metabolic optimization or weight-loss, for these the benefits of GLP1-RAs probably outweigh the benefits by far, especially that even short to medium term use might bring measurable benefits, especially if accompanied by exercise and improved nutrition.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
It should be clear that my risk/benefit profile does not apply to most people in need of metabolic optimization or weight-loss, for these the benefits of GLP1-RAs probably outweigh the benefits by far, especially that even short to medium term use might bring measurable benefits, especially if accompanied by exercise and improved nutrition.